# Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial

Study · id `cardio:ct-nct02129634` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02129634](<https://clinicaltrials.gov/study/NCT02129634>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02129634

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.

## Technical summary

Registry record NCT02129634. Randomized; double masking; primary purpose treatment. Start 2013-12-27 (actual); primary completion 2018-10-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 136 participants (enrolled count; ClinicalTrials.gov record NCT02129634, source copy `cardio:ctgov-nct02129634-2019-08-20`, retrieved 2026-10-31)
- Started: 2013-12-27 (actual) (ClinicalTrials.gov record NCT02129634, source copy `cardio:ctgov-nct02129634-2019-08-20`, retrieved 2026-10-31)
- Primary completion: 2018-10-06 (actual) (ClinicalTrials.gov record NCT02129634, source copy `cardio:ctgov-nct02129634-2019-08-20`, retrieved 2026-10-31)
- Completion: 2018-10-06 (actual) (ClinicalTrials.gov record NCT02129634, source copy `cardio:ctgov-nct02129634-2019-08-20`, retrieved 2026-10-31)
- Countries: Singapore (ClinicalTrials.gov record NCT02129634, source copy `cardio:ctgov-nct02129634-2019-08-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02129634-2019-08-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial
- Acronym: SINGA-PACLI
- Condition: Peripheral Arterial Disease
- Intervention (Device): CB-PTA
- Intervention (Device): DEB-PTA
- Lead sponsor: Singapore General Hospital
- Lead sponsor class: OTHER
- Collaborator: Tan Tock Seng Hospital
- Collaborator class: OTHER
- Collaborator: Duke-NUS Graduate Medical School
- Collaborator class: OTHER
- Collaborator: Singapore Clinical Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Singapore General Hospital (`cardio:org-singapore-general-hospital`)
- Registry lists this organization as a collaborator: Tan Tock Seng Hospital (`cardio:org-tan-tock-seng-hospital`)
- Registry lists this organization as a collaborator: Duke-NUS Graduate Medical School (`cardio:org-duke-nus-graduate-medical-school`)
- Registry lists this organization as a collaborator: Singapore Clinical Research Institute (`cardio:org-singapore-clinical-research-institute`)

## Provenance

Content hash: 8012b60345495b79be530b434a1d8669f11119085f6dd0028a5f5de3d1e49e4b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
